SEC FORM
3
SEC Form 3
FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
OMB APPROVAL |
OMB Number: |
3235-0104 |
Estimated average burden |
hours per response: |
0.5 |
|
|
1. Name and Address of Reporting Person*
(Street)
ABBOTT PARK |
IL |
60064-6092 |
|
2. Date of Event Requiring Statement
(Month/Day/Year) 12/09/2011
|
3. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES
[ ABT ]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X |
Director |
|
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
5. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
Table I - Non-Derivative Securities Beneficially Owned |
1. Title of Security (Instr.
4)
|
2.
Amount of Securities Beneficially Owned (Instr.
4)
|
3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
4. Nature of Indirect Beneficial Ownership (Instr.
5)
|
Common shares without par value |
0 |
D |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivative Security (Instr.
4)
|
2. Date Exercisable and Expiration Date
(Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
6. Nature of Indirect Beneficial Ownership (Instr.
5)
|
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Explanation of Responses: |
|
John A. Berry, by Power of Attorney for Sally E. Blount |
12/16/2011 |
|
** Signature of Reporting Person |
Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
POWER OF ATTORNEY
The undersigned constitutes and appoints LAURA J. SCHUMACHER, JOHN A. BERRY,
and STEVEN L. SCROGHAM, and each of them individually, as the undersigned's
true and lawful attorney-in-fact and agent, with full power of substitution
and resubstitution, for the undersigned and in the undersigned's name, place
and stead, to prepare and sign any and all Securities and Exchange
Commission ("SEC") Notices of Proposed Sales of Securities pursuant to Rule
144 under the Securities Act of 1933 on Form 144, all SEC statements on
Forms 3, 4 and 5 as required under Section 16(a) of the Securities
Exchange Act of 1934, and any amendments to such forms, and to file the
same with all exhibits thereto, and other documents in connection therewith,
with the SEC, granting unto said attorney-in-fact and agent full power
and authority to do and perform each act and thing requisite and necessary
to be done under said Rule 144 and Section 16(a), as fully for all intents
and purposes as the undersigned might or could do in person, hereby
ratifying and confirming all that said attorney-in-fact and agent may
lawfully do or cause to be done by virtue hereof.
A copy of this power of attorney shall be filed with the SEC. The
authorization set forth above shall continue in full force and effect
until the undersigned is no longer required to file Forms 144, 3, 4, or
5 or if earlier, until the undersigned revokes such authorization by
written instructions to the attorney-in-fact.
Date: December 13, 2011
/s/ Sally E. Blount
Signature of Reporting Person
Sally E. Blount, Ph.D., Director
Name
Abbott Laboratories
100 Abbott Park Road
Abbott Park, IL 60064-6400